We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GBFH:NASDAQGBank Financial Holdings Inc. Analysis

Data as of 2026-04-05 - not real-time

$27.47

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

GBank Financial Holdings (GBFH) is trading at $27.47, just above its 20‑day SMA (26.63) but well below the 50‑day (30.18) and 200‑day (35.57) averages, signaling a short‑term technical edge amid a longer‑term bearish bias. The MACD histogram is positive and the line sits above the signal, offering a bullish counter‑signal, while the RSI at 47.8 suggests the stock is neither overbought nor oversold. Fundamentally, revenue is up 29% YoY, operating margins exceed 50%, and the forward PE of 7.8 contrasts with a trailing PE of 19, indicating a valuation gap; the DCF fair value of $28.72 implies a modest upside of roughly 4‑5% with a broader upside potential of 57% per the model. Volatility remains high at 36% and volume is decreasing, and the company pays no dividend, making cash‑flow sustainability a key watch point.
Overall, the stock appears slightly undervalued with strong earnings momentum, but the high volatility, bearish longer‑term trend, and sector‑specific credit and regulatory risks temper enthusiasm, suggesting a cautious but optimistic stance for medium‑to‑long‑term investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price hovering just above support at $23.87
  • bearish longer‑term SMA alignment
  • decreasing trading volume

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • 29% revenue growth and >50% operating margin
  • forward PE of 7.8 indicating valuation upside
  • DCF fair value above current price

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • low beta (0.79) suggesting stable price dynamics
  • strong cash position relative to debt
  • regional bank niche with sustainable earnings growth

Key Metrics & Analysis

Financial Health

Revenue Growth29.40%
Profit Margin29.00%
P/E Ratio19.1
ROE13.66%
ROA1.69%
P/B Ratio2.4
Op. Cash Flow$9.6M
Industry P/E16.6

Technical Analysis

TrendBearish
RSI47.8
Support$23.87
Resistance$30.57
MA 20$26.63
MA 50$30.18
MA 200$35.57
MACDBullish
VolumeDecreasing
Fear & Greed Index78.8

Valuation

Fair Value$28.72
Target Price$43.17
Upside/Downside57.14%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta0.79
Volatility36.36%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.